ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,514.00
      1.00%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,838.59
      -0.11%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Achilles Therapeutics PLC (ACHL)

      7. Achilles Therapeutics PLC (ACHL) Financials

      Achilles Therapeutics PLC

      Achilles Therapeutics PLC (ACHL)

      NASDAQ
      0.828899
      -0.0091
      (-1.09%)
      Closed July 27 4:00PM
      Delayed by 15 minutes
      0.828899
      0.00
      (0.00%)
      After Hours: 6:56PM
      Delayed by 15 minutes

      Achilles Therapeutics PLC Financial Summary

      The current ACHL market cap is 34.05M. The company's latest EPS is USD and P/E is N/A.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 1.09M
      Operating Income -17.46M
      Net Income -17.51M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 0531k3.13M7.32M6.08M
      Operating Income -13.76M-33.2M-61.06M-71.13M-66.78M
      Net Income -13.99M-33.2M-61.1M-71.18M-69.67M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 207.64M
      Total Liabilities 22.46M
      Total Equity 185.17M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 105.21M218.92M317.11M220.36M161.46M
      Total Liabilities 3.86M29.55M27.58M23.31M19.09M
      Total Equity 101.35M189.37M289.53M197.04M142.37M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating N/A
      Investing N/A
      Financing N/A
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -14.14M-25.25M-59.28M-59.54M-48.45M
      Investing -942k-11.85M-7.63M-7.51M-1.1M
      Financing 93.62M113.7M160.76M1,0009k

      Stats and Ratios

      Market Cap 34.05M
      Price to Earnings Ratio N/A
      Price to Sales Ratio 0
      Price to Cash Ratio 0
      Price to Book Ratio 0
      Dividend Yield -

      Share Statistics

      Shares Outstanding 41.08M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 0.44 (35.52%)

      Company Info

      Company Name Achilles Therapeutics PLC
      Address 245 hammersmith road
      london W6 8PW
      Website https://www.achillestx.com
      Industry pharmaceutical preparations (2834)